Celrixafor 24mg (Plerixafor Vials) 24mg/1.2ml

Celrixafor 24mg vials contain plerixafor, a medication used to mobilize stem cells for collection prior to transplant. This 24mg/1.2ml formulation supports stem cell therapy protocols. Store at 15-25°C. Seek medical guidance before use.

Strength

24mg/1.2ml

Pack Size

Storage

15-25°

Manufacturer / TM Owner

Admac Life Sciences

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Celrixafor 24mg vials are used to help release stem cells from bone marrow into the bloodstream for collection in patients preparing for stem cell transplant. It supports stem cell mobilization in adults undergoing autologous transplant procedures. This medication is part of supportive care in certain cancer treatment pathways.

Side Effects

After administration, Celrixafor 24mg works by blocking a protein that traps stem cells in the bone marrow, allowing them to move into the blood for collection. Common effects include mild to moderate reactions at the injection site, such as redness or discomfort.

Precautions & Warnings

Celrixafor 24mg should be handled with care and administered by healthcare professionals. Keep vials refrigerated until use and protect from light. Avoid exposure to extreme temperatures. Report any unusual symptoms to a medical provider promptly.

Avoid Interactions

Celrixafor 24mg may interact with other medications that affect stem cell release or blood cell counts. Caution is advised when combining with drugs that influence the hematopoietic system. Always inform your healthcare provider about all medications being taken.

References

Frequently Asked Questions

Celrixafor 24mg is used to help mobilize stem cells from bone marrow into the bloodstream for collection before transplant procedures.

Celrixafor 24mg is typically given as an injection under medical supervision, usually 11 hours before stem cell collection.

Celrixafor 24mg is a prescription medication and should only be obtained through licensed pharmacies or healthcare providers.

Common effects may include injection site reactions such as redness or discomfort.

Safety during pregnancy has not been established; consult a healthcare provider for personalized advice.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.